Across TCGA pan-cancer cohorts, MED15P7 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MED15P7’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MED15P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MED15P7 is over-expressed in tumor.
UCEC and PRAD are the cancer types where MED15P7 tumor–normal differential expression is most reproducible.